# Arrowhead Pharmaceuticals, Inc.: Form 10-K/A for the period ended Sep 30, 2024

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 10-K/A
- Filed: 2025-10-10
- Accepted by EDGAR: Oct 10, 2025, 16:02 ET
- Period: 2024-09-30
- Accession: 0000879407-25-000013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000087940725000013/arwr-20240930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000087940725000013/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000087940725000013/arwr-20240930.htm

Filed Oct 10, 2025.
Source: SEC EDGAR, the filing index for accession 0000879407-25-000013. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.